Savior LLC’s Astrana Health ASTH Stock Holding History

Savior LLC’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-305	Closed	-$28K	–	222
2021 Q3	$28K	Hold	305	–	–	0.03%	74
2021 Q2	$19K	Hold	305	–	–	0.02%	295
2021 Q1	$8K	Hold	305	–	–	0.01%	476
2020 Q4	$6K	Buy	+305	New	+$5.48K	﹤0.01%	534

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Savior LLC's ASTH Position: Q4 2021 in Review

Savior LLC sold out of Astrana Health (ASTH) in Q4 2021, closing a stake of 305 shares — an estimated $28K sold.

Savior LLC first reported a position in ASTH in Q4 2020 and held it in 4 quarters. The position peaked at $28K in Q3 2021. 149 funds tracked by Wall St. Rank hold ASTH as of Q4 2021.

Savior LLC reported no remaining Astrana Health position as of Q4 2021 after selling out during the quarter.
Savior LLC sold 305 Astrana Health shares in Q4 2021, an estimated $28K.
Savior LLC first reported a position in Astrana Health in Q4 2020 and held it in 4 quarters.
Savior LLC's Astrana Health position peaked at $28K in Q3 2021.
149 funds tracked by Wall St. Rank held Astrana Health as of Q4 2021.

Based on Savior LLC's 13F filing for Q4 2021, filed 3 Feb 2022.